The role of the Molecular Genetics Core in this project is to provide technical assistance to projects #2 and #3, as well as generate a molecular genetics database to be shared with all the components of this program project. The assistance will involve candidate gene direct sequencing, mouse mapping and genotyping and candidate gene LOH analysis of systemic regions of human chromosomes for Project 2 of the for Project 2. Assistance for Project 3 will involve the analysis of microsatellite instability and sequencing of mismatch repair genes hMSH2 and hMLH1 [when necessary hMSH3, hMSH6 and hPMS2], sequencing of mismatch repair genes hMSH2 and hMSH2 and hMLH1[ when necessary hMSH3, hMSH6 and hPMS2], and sequencing of exons 5-9 of p53 gene and sequencing of codons 12/13 and 61 in the K-ras gene in rectal carcinoma samples. In addition, simple repeat sequences in the coding regions of the Transforming Growth Factor-b1 Type II Receptor (TGF-b1RII), the Insulin-Like Growth Factor II Receptor (IGFII2), BAX, b-catenin and Tcf-4 will be examined to analyze MMR-Pathway and Aneuploid- Pathway alterations present in the tumor samples. The Core contains state of the art molecular biology equipment, including two Applied Biosystems 3948 nucleic acid synthesis and purification systems (48 column capacity each), six Applied Biosystems Prism 377 DNA sequencers. Primary data, analyzed with the assistance of our Shared Computer Facility, will be provided to Principal Investigators of the other projects in clearly understandable formats. Because different steps are involved in the generation of primary data, results will be verified together with other Principal Investigators to eliminate any source of potential errors. By providing primary data concerning the indicated genetic analysis, the Molecular Genetics Core will allow to correlate genetic and clinico-pathological data, thereby giving the opportunity to examine the role of these genes in rectal tumorigenesis. Interaction of the Molecular Genetics Core with all the components involved in this project is a necessary element for the fulfillment of the primary objectives set for the project in its entirety.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
3P01CA072027-03S1
Application #
6653308
Study Section
Subcommittee G - Education (NCI)
Project Start
2002-09-01
Project End
2003-08-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
3
Fiscal Year
2002
Total Cost
$296,752
Indirect Cost
Name
Thomas Jefferson University
Department
Type
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Nnadi, Stephanie C; Watson, Rayneisha; Innocent, Julie et al. (2012) Identification of five novel modifier loci of Apc(Min) harbored in the BXH14 recombinant inbred strain. Carcinogenesis 33:1589-97
Sevignani, Cinzia; Calin, George A; Siracusa, Linda D et al. (2006) Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome 17:189-202
Markova, Marina; Koratkar, Revati A; Silverman, Karen A et al. (2005) Diversity in secreted PLA2-IIA activity among inbred mouse strains that are resistant or susceptible to Apc Min/+ tumorigenesis. Oncogene 24:6450-8
Koratkar, Revati; Silverman, Karen A; Pequignot, Ed et al. (2004) Analysis of reciprocal congenic lines reveals the C3H/HeJ genome to be highly resistant to ApcMin intestinal tumorigenesis. Genomics 84:844-52
Charara, Mona; Edmonston, Tina Bocker; Burkholder, Susan et al. (2004) Microsatellite status and cell cycle associated markers in rectal cancer patients undergoing a combined regimen of 5-FU and CPT-11 chemotherapy and radiotherapy. Anticancer Res 24:3161-7
Boman, Bruce M; Walters, Rhonda; Fields, Jeremy Z et al. (2004) Colonic crypt changes during adenoma development in familial adenomatous polyposis: immunohistochemical evidence for expansion of the crypt base cell population. Am J Pathol 165:1489-98
Stein, David E; Mahmoud, Najjia N; Anne, Pramila Rani et al. (2003) Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma. Dis Colon Rectum 46:448-53
Ghiselli, Giancarlo; Coffee, Nefeteria; Munnery, Christine E et al. (2003) The cohesin SMC3 is a target the for beta-catenin/TCF4 transactivation pathway. J Biol Chem 278:20259-67
Silverman, Karen A; Koratkar, Revati A; Siracusa, Linda D et al. (2003) Exclusion of Madh2, Madh4, and Madh7 as candidates for the modifier of Min 2 (Mom2) locus. Mamm Genome 14:119-29
Cutler, N Shane; Graves-Deal, Ramona; LaFleur, Bonnie J et al. (2003) Stromal production of prostacyclin confers an antiapoptotic effect to colonic epithelial cells. Cancer Res 63:1748-51

Showing the most recent 10 out of 15 publications